Compare DRS & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRS | FMS |
|---|---|---|
| Founded | 1969 | 1996 |
| Country | United States | Germany |
| Employees | N/A | 108165 |
| Industry | Military/Government/Technical | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 11.6B |
| IPO Year | 2021 | N/A |
| Metric | DRS | FMS |
|---|---|---|
| Price | $48.64 | $23.01 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 6 | 2 |
| Target Price | ★ $49.33 | $30.00 |
| AVG Volume (30 Days) | ★ 789.9K | 654.2K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | 0.91% | ★ 2.57% |
| EPS Growth | ★ 28.75 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $3,648,000,000.00 | N/A |
| Revenue This Year | $8.14 | N/A |
| Revenue Next Year | $6.54 | $3.83 |
| P/E Ratio | $216.02 | ★ $15.62 |
| Revenue Growth | ★ 12.80 | N/A |
| 52 Week Low | $32.43 | $20.02 |
| 52 Week High | $50.04 | $28.96 |
| Indicator | DRS | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 60.95 |
| Support Level | $38.83 | $22.50 |
| Resistance Level | N/A | $24.02 |
| Average True Range (ATR) | 1.70 | 0.31 |
| MACD | 0.19 | 0.18 |
| Stochastic Oscillator | 67.98 | 97.80 |
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. It is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.